Organization · Venture Capital
Sigma Square Capital
Sigma Square Capital is a Beijing-based investment organization focused on high-growth emerging industries, particularly in healthcare, technology, and financial sectors. It primarily targets growth-stage projects in China.
Overview
What Sigma Square Capital does
What Sigma Square Capital is
Sigma Square Capital is a Beijing-based investment organization focused on high-growth emerging industries, particularly in healthcare, technology, and financial sectors. It primarily targets growth-stage projects in China.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- April 28, 2026
Official channels
Find Sigma Square Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Sigma Square Capital as a funder
Investment thesis
Sigma Square Capital focuses on high-growth emerging industries in China, investing in visionary entrepreneurs through a research-led growth-equity lens.
Focus narrative
Sigma Square Capital invests in emerging sectors including the internet, consumer upgrades, healthcare, and financial technology. The organization specifically targets growth-stage projects, focusing on funding rounds from Series A to Series C.
Value beyond capital
Sigma Square Capital adds value to its portfolio companies through deep research and first-hand information, helping entrepreneurs navigate high-growth markets and scale their businesses effectively.
Focus and fit
- Stages
- Series A · Series A+ · Series B · Series B+ · Series C · Growth Equity
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded notable exits
- Novogene
Portfolio context
Notable portfolio companies include ABclonal, a life-science tools and diagnostic reagent company; Waytous, an autonomous mining and intelligent-vehicle systems company; and Novogene, a genomics and bioinformatics company that achieved an IPO in 2021.
Common questions
What to know about Sigma Square Capital
Upseed classifies Sigma Square Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 28, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.